White Paper · AI & Privacy · Governance

AI Governance Committee Charter for Healthcare and Regulated Businesses

A committee is useful only when its charter turns AI questions into decisions: who can approve a use case, what facts must be supplied, which legal and security triggers require escalation, what evidence is retained, and who can stop a deployment.

By Lincoln Square Law · 9-minute read

A committee is an operating control, not a meeting series

No general law requires every company to create an “AI Governance Committee.” The committee is a governance mechanism: a way to assign responsibility, gather cross-functional facts, and document decisions when AI touches regulated data or consequential activity. That distinction should appear in the charter. The purpose is not to create a ceremonial board that receives presentations. The purpose is to establish decision rights, required inputs, escalation thresholds, and an evidence trail.

NIST’s AI Risk Management Framework is useful because its Govern function is cross-cutting and its Map, Measure, and Manage functions assume defined ownership and continuous lifecycle work. A charter should translate those ideas into the company’s actual structure. It should say which systems must enter review, which functions have standing seats, what the committee may approve, what must go to executive leadership or counsel, and what happens when the committee lacks enough information to decide.

Define jurisdiction before membership

Start with the committee’s jurisdiction. A practical scope is broader than “models built by Data Science.” It should reach purchased software, embedded AI features, generative assistants, automated scoring, biometric or video analytics, and material changes to an approved system. It should cover pilots when real customer, patient, employee, applicant, or confidential business data is involved. It should also cover renewals where the vendor has added AI functionality or changed data-use terms.

The charter should identify exclusions carefully. A calculator or deterministic rules engine may not need committee review merely because a vendor markets it as intelligent. Conversely, a familiar platform may need review after a feature update changes the data or decision path. Use an intake definition centered on function, data, affected people, and decision impact. Let the committee or designated triage owner resolve edge cases rather than asking every employee to make a legal classification alone.

Give each seat a reason to exist

For healthcare and other regulated businesses, the standing group usually needs Legal, Privacy, Security, Compliance, IT or Enterprise Architecture, Procurement, and a business or clinical owner. HR should participate when employment uses are in scope. Risk, Internal Audit, Quality, or Records Management may be standing or rotating members depending on the organization. The charter should identify a chair and secretary or program manager so agenda ownership and evidence retention do not disappear between meetings.

Avoid “everyone owns it” language. Legal owns legal interpretation, Security owns security control evaluation, Privacy owns data-use and notice analysis, Procurement owns contract workflow, the system owner owns the factual description and business purpose, and Compliance or the program office owns the governance process. The committee makes the cross-functional decision. Assigning those roles explicitly prevents the common failure in which each team assumes another team confirmed the hard fact.

Require a minimum intake package

The charter should prohibit substantive approval from a slide deck that says only what the vendor promises. Require a minimum intake: use-case statement, business owner, users and affected people, data categories, inputs and outputs, decision influenced, automation level, human review, deployment geography, vendor and model, data retention, training or secondary use, subprocessors where relevant, security review status, contract status, and material known limitations.

Attach screenshots or workflow diagrams if they answer how the system actually operates.

The intake should also identify unknowns. “Unknown whether prompts train a shared model” is a valid fact status. It is not a reason to fill the blank with optimism. The committee can condition approval on resolving the unknown, limit the pilot to synthetic data, or decline the deployment. The charter should expressly authorize conditional approvals and specify who verifies the condition before launch.

Build a healthcare lane around HIPAA facts

For a HIPAA covered entity or business associate, AI governance must connect to existing Security Rule and Privacy Rule processes rather than creating a parallel universe. Section 164.308 requires risk analysis, risk management, assigned security responsibility, access management, training, incident procedures, contingency planning, and evaluation. An AI system handling ePHI should therefore enter the existing risk-management record, with the AI committee adding the use-case, model, vendor, and decision questions that ordinary security review may not capture.

The vendor path matters too. When an AI provider is a business associate, the contract must satisfy the HIPAA requirements applicable to business associate arrangements, including permitted uses, safeguards, reporting, subcontractor flow-down, access to records, return or destruction where feasible, and termination rights for material breach. The committee should not “approve AI” while the BAA, security exhibit, or data-use terms remain unresolved.

Make legal and security contract completion a release condition.

Create automatic escalation triggers

The charter should list facts that require enhanced review. Examples include decisions about hiring, promotion, discipline, access to healthcare, patient prioritization, eligibility, pricing, credit, safety, or other significant interests. Other examples include use of biometric identifiers, ePHI or other sensitive data, autonomous external action, generation of clinical or legal recommendations, high-volume monitoring, model training on company data, and inability to explain or reproduce a consequential output. The list can be tailored, but the principle is important: high-impact facts should not depend on whether a meeting attendee remembers to raise them.

Illinois employment AI provides a concrete example. Section 2-102(L) of the Human Rights Act regulates AI used in specified employment activities and requires employee notice, while BIPA creates a separate pre-collection gate if covered biometric data is involved. The committee should route those facts to employment and privacy analysis automatically. That is how the charter converts legal change into repeatable operations.

Write decision rights, quorum, and vetoes with precision

A charter should state what counts as approval. Define quorum, required functions for specific decisions, and whether certain risk owners have a blocking right. For example, a deployment involving ePHI should not be approvable without Security and Privacy participation, a hiring use should not proceed without Employment or Legal review, and an unresolved BAA should block a healthcare go-live. The committee may delegate low-risk approvals to a triage owner, but the delegation should be documented and bounded.

Also define the appeal path. Business urgency does not eliminate risk. It changes who accepts it. If a business sponsor wants to proceed over a control owner’s objection, require a written escalation to a named executive with the unresolved issue, alternatives, mitigation, and expiration date. Do not let “the committee approved” become a phrase that hides dissent or missing facts. The record should show the actual decision.

Document conditions, expiration, and material change

Approvals should not be permanent. Record the approved purpose, data, users, geography, model or feature, human-review design, vendor terms, conditions, and review date. Define material-change triggers: new decision purpose, new data class, new population, new model, changed training practice, changed subprocessor, changed retention, removal of human review, new jurisdiction, or a significant incident. A material change should reopen review before the change becomes ordinary production use.

The evidence package should include the intake, assessments, meeting decision, dissent or conditions, vendor diligence, contract references, notices, testing evidence, and the final approved configuration. Keep a short decision memo that a future reviewer can understand without replaying the meeting. The committee’s credibility depends less on meeting minutes than on whether it can show what facts were considered and what was actually authorized.

Tie procurement and change management to the charter

The charter fails if participation is optional. Procurement should ask whether the product uses AI, automated decisioning, biometrics, or sensitive-data processing and route qualifying purchases before signature. IT change management should identify material feature changes. Contract owners should trigger review before renewal.

Employees need a simple path to disclose free or self-procured AI tools. The committee should receive these feeds rather than relying on an annual discovery exercise.

For vendor terms, focus on evidence and control: permitted data use, model training, confidentiality, security, subprocessors, incident notification, change notice, audit evidence, deletion, data return, intellectual property, output responsibility, and termination assistance. Where the service handles regulated data, align the AI terms with the BAA, DPA, and security exhibit instead of allowing inconsistent promises across documents.

Measure whether the governance system is working

A useful committee dashboard is small: number of active AI use cases, high-risk use cases, overdue conditions, unknowns awaiting vendor response, systems with upcoming renewals, incidents, material changes, unapproved discoveries, and review cycle age. Add a sampling metric: periodically select approved systems and verify that configuration, data use, notices, and contract terms still match the record. A perfect inventory with no verification can become inaccurate quickly.

Review the charter at least annually and after a material legal or organizational change. The goal is not to make the committee larger. It is to make the path from discovery to decision faster and more reliable. If low-risk reviews are clogging meetings, delegate them. If high-risk tools are appearing after signature, fix procurement routing. If decisions cannot be reconstructed, improve evidence standards. Governance should become more efficient as the organization learns, not more ceremonial.